Financial Performance - Sino Harbour Holdings Group Limited reported a revenue of HKD 1.2 billion for FY2021, representing a 15% increase compared to FY2020[8]. - The company achieved a net profit of HKD 300 million for FY2021, which is a 20% increase year-on-year[8]. - The company has outlined a future outlook with a revenue growth target of 10-15% for FY2022[8]. - The company provided a positive outlook, projecting a revenue growth of 20% for the next fiscal year[10]. - Profit attributable to the owners of the Company amounted to approximately RMB57.5 million in FY2021[28]. - The Group recorded a net cash outflow of approximately RMB318.7 million from operating activities in FY2021, mainly due to an increase in prepayments and other receivables[74]. - The Group's financial performance and cash flows for the Year are detailed in pages 111 to 232 of the annual report[129]. Market Expansion and Strategy - User data indicated a growth in active clients by 25%, reaching a total of 50,000 clients by the end of FY2021[8]. - The company plans to expand its market presence in Southeast Asia, targeting a 30% increase in market share over the next two years[8]. - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by the end of the next fiscal year[10]. - The company plans to open three new offices in key cities, which is expected to boost operational efficiency by 15%[10]. - Sino Harbour is exploring potential acquisitions to enhance its property portfolio, aiming for a 20% increase in asset value[8]. - The Group is exploring other possible business areas and seeking to expand into new sectors, although experiences may not be applicable to these new sectors[118]. Investment and Development - Sino Harbour is investing HKD 100 million in new product development, focusing on innovative technologies in the real estate sector[8]. - Investment in new technology development increased by 30%, totaling HK$150 million[10]. - The Group aims to expand its pharmaceutical R&D and medical-related businesses to enhance competitiveness[30]. - The Group's pharmaceutical R&D services are expected to create synergies with other business segments, aiming for stable progress in the current year[38]. Dividends and Shareholder Value - The final dividend for FY2021 is set at HKD 0.05 per share, reflecting a commitment to returning value to shareholders[8]. - The proposed final dividend for FY2021 is HK$0.01 per share, equivalent to SGD 0.173 per share, consistent with FY2020[104]. - The final dividend is subject to shareholder approval at the 2021 AGM scheduled for August 20, 2021[106]. Operational Efficiency - The company has implemented new strategies to improve operational efficiency, expecting a reduction in costs by 5% in the upcoming fiscal year[8]. - A new marketing strategy was introduced, aiming to increase brand awareness by 40% over the next year[10]. Real Estate Market Insights - The Group maintains confidence in the future of the real estate market, believing it will provide stable and substantial returns to investors[34]. - The real estate market in China is expected to stabilize and rebound in the second half of 2021, with a V-shaped recovery noted in 2020[94]. - The highest land sales in China reached RMB 117.8 billion in Hangzhou, indicating positive future expectations for the real estate market[95]. - In Q1 2021, the real estate market in first-tier cities saw a price increase of 0.78%, the highest in four years, while second-tier cities experienced a price increase of 0.76% due to ongoing policy adjustments[97]. Financial Position and Assets - The cash and cash equivalents for FY2021 were RMB92.2 million, showing a significant increase from previous years[24]. - The net assets of the Company reached RMB1,656.4 million in FY2021, reflecting a stable financial position[22]. - The Group's investment properties at fair value increased to approximately RMB1,127.3 million as of March 31, 2021, compared to approximately RMB849.2 million as of March 31, 2020, mainly due to the transfer from properties held for sale[55]. - Properties held for sale decreased from approximately RMB1,064.6 million as of March 31, 2020, to approximately RMB542.8 million as of March 31, 2021, primarily due to the handover of completed property units[58]. Compliance and Governance - The Group has complied with all relevant laws and regulations that significantly impact its operations during the Year[125]. - The Group maintains good relationships with employees, customers, and suppliers, recognizing their importance for sustainable development[126]. - The Company did not redeem any of its listed securities during FY2021, nor did it purchase or sell such securities[142]. Employee and Management Information - The group employed 240 staff as of March 31, 2021, with employee costs amounting to approximately RMB 37.2 million, a slight decrease from RMB 38.1 million in the previous year[83]. - The Directors' emoluments are determined based on the Group's operating results and individual performance[173]. - Each Executive Director has a service contract for a term of three years, subject to re-election at AGMs[159].
汉港控股(01663) - 2021 - 年度财报